{
  "company_number": "08512653",
  "name": "Lynam Pharma Limited",
  "url": "/company/08512653",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2013-05-01",
  "dissolved_on": null,
  "sic_codes": [
    "86900"
  ],
  "registered_address": {
    "id": 1653481,
    "url": "/address/1653481",
    "line1": "73 SOUTHERN ROAD",
    "line2": "",
    "post_town": "THAME",
    "county": "OXFORDSHIRE",
    "country": "",
    "postcode": "OX9 2ED"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08512653",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-02-28",
    "last_made_up": "2025-05-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/08512653/accounts/2025-05-31",
        "made_up_date": "2025-05-31",
        "period_start": "2025-05-31",
        "period_end": "2025-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "42147.00",
        "debtors": "379387.00",
        "cash_bank_in_hand": "5772.00",
        "current_assets": "389558.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-647823.00",
        "total_assets_less_current_liabilities": "-605676.00",
        "net_assets_liabilities": "-605676.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Bulk_Data-2026-06-02.zip"
      },
      {
        "url": "/company/08512653/accounts/2024-05-31",
        "made_up_date": "2024-05-31",
        "period_start": "2024-05-31",
        "period_end": "2024-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "3403.00",
        "debtors": "20631.00",
        "cash_bank_in_hand": "98822.00",
        "current_assets": "135083.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-278747.00",
        "total_assets_less_current_liabilities": "-275344.00",
        "net_assets_liabilities": "-275344.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2025.zip"
      },
      {
        "url": "/company/08512653/accounts/2023-05-31",
        "made_up_date": "2023-05-31",
        "period_start": "2023-05-31",
        "period_end": "2023-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": "6.00",
        "tangible_fixed_assets": "7156.00",
        "debtors": "51679.00",
        "cash_bank_in_hand": "969.00",
        "current_assets": "68331.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-92668.00",
        "total_assets_less_current_liabilities": "-85512.00",
        "net_assets_liabilities": "-150791.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2024.zip"
      },
      {
        "url": "/company/08512653/accounts/2022-05-31",
        "made_up_date": "2022-05-31",
        "period_start": "2022-05-31",
        "period_end": "2022-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": "6.00",
        "tangible_fixed_assets": "5973.00",
        "debtors": "39473.00",
        "cash_bank_in_hand": "46503.00",
        "current_assets": "93819.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-1063.00",
        "total_assets_less_current_liabilities": "4910.00",
        "net_assets_liabilities": "-77035.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2023.zip"
      },
      {
        "url": "/company/08512653/accounts/2021-05-31",
        "made_up_date": "2021-05-31",
        "period_start": "2021-05-31",
        "period_end": "2021-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "8533.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "60625.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "3384.00",
        "total_assets_less_current_liabilities": "11917.00",
        "net_assets_liabilities": "11917.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "11917.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2022.zip"
      },
      {
        "url": "/company/08512653/accounts/2020-05-31",
        "made_up_date": "2020-05-31",
        "period_start": "2020-05-31",
        "period_end": "2020-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "5914.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "33856.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2974.00",
        "total_assets_less_current_liabilities": "2940.00",
        "net_assets_liabilities": "2140.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2140.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2021.zip"
      },
      {
        "url": "/company/08512653/accounts/2019-05-31",
        "made_up_date": "2019-05-31",
        "period_start": "2019-05-31",
        "period_end": "2019-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "6090.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "42619.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "5176.00",
        "total_assets_less_current_liabilities": "914.00",
        "net_assets_liabilities": "114.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "114.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2020.zip"
      },
      {
        "url": "/company/08512653/accounts/2018-05-31",
        "made_up_date": "2018-05-31",
        "period_start": "2018-05-31",
        "period_end": "2018-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "6056.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "44648.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "19921.00",
        "total_assets_less_current_liabilities": "25977.00",
        "net_assets_liabilities": "24997.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "24997.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-December2018.zip"
      },
      {
        "url": "/company/08512653/accounts/2017-05-31",
        "made_up_date": "2017-05-31",
        "period_start": "2017-05-31",
        "period_end": "2017-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "412.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "41564.00",
        "creditors_due_within_one_year": "31202.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "10779.00",
        "total_assets_less_current_liabilities": "11191.00",
        "net_assets_liabilities": "10091.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "10091.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2018.zip"
      },
      {
        "url": "/company/08512653/accounts/2016-05-31",
        "made_up_date": "2016-05-31",
        "period_start": "2016-05-31",
        "period_end": "2016-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "122.00",
        "debtors": "10150.00",
        "cash_bank_in_hand": null,
        "current_assets": "18650.00",
        "creditors_due_within_one_year": "18644.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "6.00",
        "total_assets_less_current_liabilities": "128.00",
        "net_assets_liabilities": "128.00",
        "called_up_share_capital": "100.00",
        "profit_loss_account_reserve": "28.00",
        "shareholder_funds": "128.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-February2017.zip"
      },
      {
        "url": "/company/08512653/accounts/2015-05-31",
        "made_up_date": "2015-05-31",
        "period_start": "2015-05-31",
        "period_end": "2015-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "2.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "2.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "2.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2016.zip"
      },
      {
        "url": "/company/08512653/accounts/2014-05-31",
        "made_up_date": "2014-05-31",
        "period_start": "2014-05-31",
        "period_end": "2014-05-31",
        "entity_name": "Lynam Pharma Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2015.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08512653/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-03-14",
    "last_made_up": "2026-02-28"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mrs Sinead Mary Patel",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/4698331",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": "2024-05-24",
      "nationality": "Irish",
      "country_of_residence": "United Kingdom",
      "source": "snapshot"
    },
    {
      "name": "Mr Shailesh Patel",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/4582634",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-50-to-75-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": "2024-05-24",
      "nationality": "British",
      "country_of_residence": "United Kingdom",
      "source": "snapshot"
    },
    {
      "name": "Laitwood Capital Ltd",
      "kind": "corporate-entity-person-with-significant-control",
      "person_url": null,
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2024-05-24",
      "ceased_on": null,
      "nationality": "",
      "country_of_residence": "",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-02T05:12:20.351914+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}